Skip to main content
. 2022 Mar 9;11(6):e022937. doi: 10.1161/JAHA.121.022937

Figure 3. Hierarchical testing of end points: patients with prior percutaneous coronary intervention treated with icosapent ethyl vs placebo.

Figure 3

HR indicates hazard ratio.